Shanghai Yaxin Biotechnology Co., Ltd.

Company Profile
Shanghai Yaxin Biotechnology Co., Ltd.
Shanghai Yaxin Biotechnology Co., Ltd. was established in 2008, a high-tech enterprise underChina National Biotec Group Company Limited (CNBG) of China National PharmaceuticalGroup Co., Ltd.(Sinopharm), focusing on R&D and production of animal-free sourced biopharmaceutical enzymes. lt is one of the drafters and formulators of the "Recombinant Trypsin Standard" of the 2020 edition of “Chinese Pharmacopoeia", and supplier of key rawmaterials in biomedicine market in China.
more >

Year of Establishment: 2008

Total Assets(USD): less than 500,000

Total Number of Staff: 50 to 59

Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Delivery Term,Production capacity,Large Product Line,Small Orders Accepted,Reputation,Quality Service

Other Competitive Advantages: Recombinant Products; Animal component-free of high purity, convenience and safety

Patents and Copyrights:

Certificates/Standards View More
Send your message to this supplier
  • From:
  • To:
    Shanghai Yaxin Biotechnology Co., Ltd.
  • Send a Copy to this Email
  • Message:
    Upload Images / Files
    - Supports jpg, jpeg, png,
     gif, pdf, doc, docx,
     xls, xlsx, txt, rar and zip
    - Max upload 3 files;
     Max  total size: 3MB
    (0/3)

    Enter between 20 to 4,000 characters.This is not what you are looking for ? Post a Sourcing Request Now

  • Verification:
PharmaSources Customer Service